Neoplasma is a peer-reviewed journal dedicated to publishing original research and reviews in the field of oncology. Its primary focus is on understanding the biological basis of cancer, including its causes, development, progression, and treatment.
The journal covers a broad range of topics within cancer research, including molecular biology, genetics, immunology, cell signaling, and experimental therapeutics. It publishes studies that use in vitro and in vivo models, as well as translational research that bridges the gap between basic science and clinical application. Neoplasma focuses on the discovery and validation of novel biomarkers, the development of new cancer therapies, and the improvement of existing treatment strategies. The journal is indexed by CAS and other databases.
Neoplasma is an essential resource for researchers, clinicians, and academics seeking to advance their understanding of cancer and improve patient outcomes. Its commitment to high-quality, peer-reviewed content ensures that readers receive the most up-to-date and reliable information. It welcomes submissions from researchers around the world and aims to foster collaboration and communication within the global cancer research community.